tiprankstipranks
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
US Market
VYGR
Voyager Therapeutics
RESEARCH TOOLSreports
Want to see VYGR full AI Analyst Report?

Voyager Therapeutics (VYGR) Stock News & Sentiment

1,346 Followers
Voyager Therapeutics Announces CFO Resignation and Finance Leadership Changes
Premium
Company Announcements
Voyager Therapeutics Announces CFO Resignation and Finance Leadership Changes
7d ago
8K
VYGR
Amazon (AMZN) Launches AI Tools to Help Accelerate Drug Discoveries
Premium
Market News
Amazon (AMZN) Launches AI Tools to Help Accelerate Drug Discoveries
14d ago
NVO
AMZN
Voyager Therapeutics: Early-Stage Tau Program Optionality Drives High-Risk, High-Upside Buy Rating
Premium
Ratings
Voyager Therapeutics: Early-Stage Tau Program Optionality Drives High-Risk, High-Upside Buy Rating
1M ago
VYGR
Voyager Therapeutics: Differentiated CNS Platform, Strategic Partnerships, and 2026 Data Catalysts Underpin Buy Rating
Premium
Ratings
Voyager Therapeutics: Differentiated CNS Platform, Strategic Partnerships, and 2026 Data Catalysts Underpin Buy Rating
1M ago
VYGR
Voyager Therapeutics: Advancing Tau-Targeted Gene Therapy with Multiple Near-Term Catalysts and Attractive Risk-Reward
Premium
Ratings
Voyager Therapeutics: Advancing Tau-Targeted Gene Therapy with Multiple Near-Term Catalysts and Attractive Risk-Reward
2M ago
VYGR
Voyager Therapeutics Faces Rising Tariff and U.S.–China Geopolitical Risks as BIOSECURE Act Threatens Key Chinese CDMO Partnerships
Premium
Company Announcements
Voyager Therapeutics Faces Rising Tariff and U.S.–China Geopolitical Risks as BIOSECURE Act Threatens Key Chinese CDMO Partnerships
2M ago
VYGR
Voyager Therapeutics: Undervalued Neurology Pipeline With High-Reward 2026 Catalysts Supports Buy Rating
Premium
Ratings
Voyager Therapeutics: Undervalued Neurology Pipeline With High-Reward 2026 Catalysts Supports Buy Rating
2M ago
VYGR
More VYGR News >

VYGR News on the Web

Amazon (AMZN) Launches AI Tools to Help Accelerate Drug Discoveries
TipRanks News
Neutral
Voyager Therapeutics management to meet with Oppenheimer
TipRanks News
Neutral
Top Executive at Voyager Therapeutics Makes Notable Stock Move
TipRanks News
Neutral
Voyager Therapeutics: Early-Stage Tau Program Optionality Drives High-Risk, High-Upside Buy Rating
TipRanks News
Bullish
Voyager Therapeutics: Differentiated CNS Platform, Strategic Partnerships, and 2026 Data Catalysts Underpin Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
TipRanks News
Bullish
Voyager Therapeutics: Advancing Tau-Targeted Gene Therapy with Multiple Near-Term Catalysts and Attractive Risk-Reward
TipRanks News
Neutral
Guggenheim Remains a Buy on Voyager Therapeutics (VYGR)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
VYGR
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VYGR’s Media Buzz Sentiment?
Currently, no data Available
What is VYGR’s weekly average amount of articles?
Currently, no data Available
What is VYGR’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week